Browse

COVID-19 and CEE: How the pandemic will affect M&A in 2021

Our survey reveals that dealmakers are cautiously optimistic about post-pandemic prospects for M&A in the region with new opportunities emerging. But challenges still lie ahead

CEE healthcare M&A value rises in 2020 with more to come in 2021

The global pandemic, ageing populations and the burgeoning biotech subsector mean that the pharmaceuticals, medical and biotech (PMB) sector is set to see robust M&A activity in 2021